
Sanofi's Pompe disease drug shortage persists over 3 months due to manufacturing issues, risking patient health.
Sanofi is facing a drug shortage for its Pompe disease treatments due to manufacturing problems at its Ireland facility, causing infusion cancellations for patients. The shortage has lasted over three months, with shipping delays expected to continue...




